Effect of ademetionine on cytochrome P450 isoforms activity in rats

被引:0
作者
Tong, Shuhua [1 ]
Guo, Jiayi [1 ]
Song, Huanchun [1 ]
Lv, Shiwen [1 ]
Zhu, Yalan [1 ]
Ma, Jianshe [2 ]
Zheng, Yuancai [3 ]
机构
[1] Jinhua Cent Hosp, Dept Clin Pharm, Jinhua 321000, Peoples R China
[2] Wenzhou Med Univ, Funct Expt Teaching Ctr, Wenzhou 325000, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou 325000, Peoples R China
关键词
CYP450; ademetionine; cocktail; UPLC-MS/MS; rat; ADENOSYL-L-METHIONINE; ALCOHOLIC LIVER-DISEASE; IN-VITRO; OXIDATIVE STRESS; MASS-SPECTROMETRY; DRUG-METABOLISM; COCKTAIL; INJURY; ACTIVATION; EXPRESSION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cocktail method was used to evaluate the influence of ademetionine on the activities of CYP450 isoforms CYP1A2, CYP2D6, CYP3A4, CYP2C19, CYP2C9 and CYP2B6, which were reflected by the changes of pharmacokinetic parameters of six specific probe drugs phenacetin, metroprolol, midazolam, omeprazole, tolbutamide and bupropion, respectively. The experimental rats were randomly divided into two group, control group and ademetionine group. The ademetionine group rats were given 50 mg/kg ademetionine by continuous oral administration for 7 days. The mixture of six probes was given to rats through oral administration and the blood samples were obtained at a series of time-points through the caudal vein. The concentrations of probe drugs in rat plasma were measured by UPLC-MS/MS. In the experiment for ademetionine and control group, there was statistical pharmacokinetics difference for phenacetin, metroprolol, midazolam, omeprazole, tolbutamide and bupropion. Continuous oral administration for 7 days could induce the activities of CYP450 isoforms CYP1A2 of rats, while it may inhibit the activities of CYP2D6, CYP3A4, CYP2C19 and CYP2C9.
引用
收藏
页码:9716 / 9722
页数:7
相关论文
共 27 条
[1]   Transporter-enzyme interactions:: Implications for predicting drug-drug interactions from in vitro data [J].
Benet, LZ ;
Cummins, CL ;
Wu, CY .
CURRENT DRUG METABOLISM, 2003, 4 (05) :393-398
[2]   Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions [J].
Bertz, RJ ;
Granneman, GR .
CLINICAL PHARMACOKINETICS, 1997, 32 (03) :210-258
[3]   Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury [J].
Cederbaum, Arthur I. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (11) :1366-1376
[4]   S-Adenosyl-L-methionine and mitochondrial reduced glutathione depletion in alcoholic liver disease [J].
Fernández-Checa, JC ;
Colell, A ;
García-Ruiz, C .
ALCOHOL, 2002, 27 (03) :179-183
[5]   Pattern of methionine adenosyltransferase isoenzyme expression during rat liver regeneration after partial hepatectomy [J].
Frago, LM ;
Giménez, A ;
Rodriguez, EN ;
Varela-Nieto, I .
FEBS LETTERS, 1998, 426 (03) :305-308
[6]  
GonzalezCorrea JA, 1997, HEPATOLOGY, V26, P121
[7]  
Guo JY, 2014, LAT AM J PHARM, V33, P1332
[8]  
Hirata-Koizumi Mutsuko, 2005, Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku, P12
[9]  
Hu LF, 2012, LAT AM J PHARM, V31, P889
[10]   Magnesium activation of GTP hydrolysis or incubation in S-adenosyl-L-methionine reverses iron-56-particle-induced decrements in oxotremorine enhancement of K+-evoked striatal release of dopamine [J].
Joseph, JA ;
Shukitt-Hale, B ;
McEwen, J ;
Rabin, B .
RADIATION RESEARCH, 1999, 152 (06) :637-641